Shionogi & Co., Ltd. (SGIOY)
9.15
-0.03
(-0.33%)
USD |
OTCM |
Aug 24, 16:00
Shionogi EPS Diluted (Quarterly) : 0.3601 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.3601 |
| March 31, 2026 | 0.1757 |
| December 31, 2025 | 0.2848 |
| September 30, 2025 | 0.1761 |
| June 30, 2025 | 0.16 |
| March 31, 2025 | 0.1412 |
| December 31, 2024 | 0.1954 |
| September 30, 2024 | 0.2067 |
| June 30, 2024 | 0.0385 |
| March 31, 2024 | 0.1372 |
| December 31, 2023 | 0.0477 |
| September 30, 2023 | 0.063 |
| June 30, 2023 | 0.0584 |
| March 31, 2023 | 0.0388 |
| December 31, 2022 | 0.1336 |
| September 30, 2022 | 0.0301 |
| June 30, 2022 | 0.0493 |
| March 31, 2022 | 0.0684 |
| December 31, 2021 | 0.0289 |
| September 30, 2021 | 0.035 |
| June 30, 2021 | 0.0543 |
| March 31, 2021 | 0.0448 |
| December 31, 2020 | 0.0632 |
| September 30, 2020 | 0.047 |
| June 30, 2020 | 0.0416 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0468 |
| December 31, 2019 | 0.1982 |
| September 30, 2019 | 0.1357 |
| June 30, 2019 | 0.1319 |
| March 31, 2019 | 0.062 |
| December 31, 2018 | 0.0572 |
| September 30, 2018 | 0.0407 |
| June 30, 2018 | 0.0509 |
| March 31, 2018 | 0.0467 |
| December 31, 2017 | 0.0447 |
| September 30, 2017 | 0.0531 |
| June 30, 2017 | 0.0247 |
| March 31, 2017 | 0.0248 |
| December 31, 2016 | 0.0562 |
| September 30, 2016 | 0.0306 |
| June 30, 2016 | 0.0195 |
| March 31, 2016 | 0.0365 |
| December 31, 2015 | 0.0281 |
| September 30, 2015 | 0.0161 |
| June 30, 2015 | 0.0134 |
| March 31, 2015 | 0.025 |
| December 31, 2014 | 0.024 |
| September 30, 2014 | -0.001 |
| June 30, 2014 | 0.0163 |
| March 31, 2014 | 0.0074 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Daiichi Sankyo Co., Ltd. | 0.2366 |
| Takeda Pharmaceutical Co., Ltd. | 0.2213 |
| Eisai Co., Ltd. | 0.1015 |
| Chugai Pharmaceutical Co., Ltd. | 0.2218 |
| Santen Pharmaceutical Co., Ltd. | 0.1399 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 613.21M |
| Revenue (Quarterly) | 1.025B |
| Total Expenses (Quarterly) | 411.75M |
| Enterprise Value | 17.95B |
| Gross Profit Margin (Quarterly) | 71.45% |
| Profit Margin (Quarterly) | 59.84% |
| Earnings Yield | 10.89% |
| Operating Earnings Yield | 6.87% |
| Normalized Earnings Yield | 10.89 |